Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...

The Court for the Central District of California has sided with Axonics finding the company did not breach Medtronic’s ...

A month has gone by since the last earnings report for Medtronic (MDT). Shares have added about 0.7% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...

Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...

Axonics (Nasdaq:AXNX) announced today that a jury unanimously ruled in its favor in a patent spat with (NYSE: MDT).

Medtronic PLC closed $2.15 below its 52-week high ($91.49), which the company reached on September 4th.

Medtronic may be an underrated beneficiary of declining interest rates. That's because as rates come down, it becomes less ...

12 ceremony. Axonics Inc. (Nasdaq: AXNX), a maker of medical devices to treat incontinence, said a jury has returned a ...

Shares of Medtronic PLC MDT slumped 0.56% to $88.13 Wednesday, on what proved to be an all-around dismal trading session for ...